| Indicators | Browse All

Filana Therapeutics, Inc. (FLNA)

Healthcare | Biotechnology | Austin, United States | NasdaqCM
0.76 USD +0.03 (3.991%) ⇧ (Oct. 15, 2026, 4 p.m. EDT)
Short-term:★☆☆☆☆Long-term:★☆☆☆☆Dividends:☆☆☆☆☆
Hot Take ↕ | Oct. 10, 2026, 7:06 a.m. EDT

Filana Therapeutics presents a classic high-risk biotech binary play where the market is pricing in a massive upside event while ignoring the fundamental reality of a distressed balance sheet. The company is trading at a fraction of its book value ($0.62 P/B) and carries significant debt, yet the options chain tells a story of aggressive speculation on a turnaround. The sheer volume of call open interest at strikes like $2.50 and $5.00 suggests traders are betting on a successful drug approval or pivotal trial readout to drive the price from its current $0.82 lows. However, the statistical forecast model offers almost no guidance, predicting a negligible 0.23% move with low confidence, which highlights the disconnect between the speculative frenzy and the underlying price mechanics. Fundamentally, the business is in a deep hole with negative returns on equity and assets, and without a confirmed catalyst, the odds favor further dilution or stagnation. This is not an investment; it is a lottery ticket purchased by those willing to bet on a specific medical breakthrough.
Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoETS ✓0.092352
MSTL0.093962
AutoTheta0.203512
AutoARIMA0.203532

Forecast horizon: 45 days | Selected: AutoETS

Forecast Reliability
Score 34%
H-stat 2.66
Ljung-Box p 0.000
Jarque-Bera p 0.167
Excess Kurtosis -0.66
Attribute Value
Sector Healthcare
Ex Dividend Date 2012-12-12
Last Dividend Date 2012-12-12
Market Cap 36,752,648
Beta -0.66
Previous Name Cassava Sciences, Inc.
Website https://www.filanatx.com

As of Oct. 10, 2026, 7:06 a.m. EDT: Speculators are overwhelmingly bullish on upside potential, evidenced by massive open interest in out-of-the-money calls (strikes $2.50 to $12.50) compared to negligible put volume. This 'call-only' skew suggests a belief in a catalyst-driven rally, likely tied to clinical trial results or regulatory milestones. However, the lack of protective puts indicates a speculative gamble rather than a hedged position, with implied volatility remaining low despite the heavy call positioning.

Dividend Data

Dividend History
Date Dividend Yield %
2012-12-13 5.25 29.644270
2010-12-13 14.00 30.395136
Additional Data
dividendYield 0.0
exDividendDate 2012-12-13
trailingAnnualDividendRate 0.0
trailingAnnualDividendYield 0.0
lastDividendValue 5.25
lastDividendDate 2012-12-13

Info Dump

Attribute Value
52 Week Change -0.8232558
Address1 6,801 N. Capital of Texas Highway
Address2 Building 1
All Time High 184.625
All Time Low 0.67
Ask 1.07
Ask Size 10
Average Daily Volume10 Day 635,950
Average Daily Volume3 Month 2,022,785
Average Volume 2,022,785
Average Volume10Days 635,950
Beta -0.66
Bid 1.13
Bid Size 10
Book Value 1.317
City Austin
Compensation As Of Epoch Date 1,767,139,200
Country United States
Crypto Tradeable 0
Currency USD
Current Price 0.7608
Current Ratio 2.085
Custom Price Alert Confidence HIGH
Date Short Interest 1,790,726,400
Day High 0.7689
Day Low 0.702
Display Name Filana Therapeutics
Dividend Yield 0.0
Earnings Timestamp 1,785,328,200
Earnings Timestamp End 1,793,277,000
Earnings Timestamp Start 1,793,277,000
Ebitda -12,688,000
Ebitda Margins 0.0
Enterprise To Ebitda 3.62
Enterprise Value -45,928,352
Eps Trailing Twelve Months -0.87
Esg Populated 0
Ex Dividend Date 1,355,356,800
Exchange NCM
Exchange Data Delayed By 15
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 0.8584
Fifty Day Average Change -0.09759998
Fifty Day Average Change Percent -0.11369989
Fifty Two Week Change Percent -82.32558
Fifty Two Week High 4.69
Fifty Two Week High Change -3.9292002
Fifty Two Week High Change Percent -0.83778256
Fifty Two Week Low 0.67
Fifty Two Week Low Change 0.09079999
Fifty Two Week Low Change Percent 0.13552237
Fifty Two Week Range 0.67 - 4.69
Financial Currency USD
First Trade Date Milliseconds 963,581,400,000
Float Shares 46,917,595
Free Cashflow 3,977,375
Full Exchange Name NasdaqCM
Full Time Employees 17
Fullday Change -0.026199996
Fullday Change Percent -3.443743
Fullday Price 0.7346
Gmt Off Set Milliseconds -14,400,000
Gross Margins 0.0
Gross Profits -15,655,000
Has Pre Post Market Data 1
Held Percent Insiders 0.020499999
Held Percent Institutions 0.26808
Implied Shares Outstanding 48,307,896
Industry Biotechnology
Industry Disp Biotechnology
Industry Key biotechnology
Ir Website http://investor.paintrials.com/stockquote.cfm
Is Earnings Date Estimate 1
Language en-US
Last Dividend Date 1,355,356,800
Last Dividend Value 5.25
Last Fiscal Year End 1,767,139,200
Last Split Date 1,494,374,400
Last Split Factor 1:7
Long Business Summary Filana Therapeutics, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is in Phase 3 clinical trial to treat Alzheimer's disease; and investigational diagnostic product candidate is SavaDx, an early-stage program focused on detecting the presence of Alzheimer's disease from a small sample of blood. The company was formerly known as Cassava Sciences, Inc. and changed its name to Filana Therapeutics, Inc. in March 2026. The company was incorporated in 1998 and is based in Austin, Texas.
Long Name Filana Therapeutics, Inc.
Market us_market
Market Cap 36,752,648
Market State PRE
Max Age 86,400
Message Board Id finmb_107567
Most Recent Quarter 1,782,777,600
Name Change Date 2,026-10-16
Net Income To Common -42,280,000
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 49,757,132
Number Of Analyst Opinions 2
Open 0.713
Operating Cashflow -28,702,000
Operating Margins 0.0
Payout Ratio 0.0
Peg Ratio 1.62
Phone 512 501 2444
Pre Market Change -0.026199996
Pre Market Change Percent -3.443743
Pre Market Price 0.7346
Pre Market Time 1,792,140,471
Prev Name Cassava Sciences, Inc.
Previous Close 0.7316
Price Hint 4
Price To Book 0.57767653
Profit Margins 0.0
Quick Ratio 2.059
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.0292
Regular Market Change Percent 3.99125
Regular Market Day High 0.7689
Regular Market Day Low 0.702
Regular Market Day Range 0.702 - 0.7689
Regular Market Open 0.713
Regular Market Previous Close 0.7316
Regular Market Price 0.7608
Regular Market Time 1,792,094,401
Regular Market Volume 248,268
Return On Assets -0.07143
Return On Equity -0.55785
Sand P52 Week Change 0.16207206
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Shares Outstanding 48,307,896
Shares Percent Shares Out 0.121800005
Shares Short 5,885,540
Shares Short Previous Month Date 1,788,134,400
Shares Short Prior Month 6,293,202
Short Name Filana Therapeutics, Inc.
Short Percent Of Float 0.1244
Short Ratio 1.16
Source Interval 15
State TX
Symbol FLNA
Target High Price 8.0
Target Low Price 5.0
Target Mean Price 6.5
Target Median Price 6.5
Total Cash 82,681,000
Total Cash Per Share 1.712
Total Debt 0
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -0.87
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 1.43665
Two Hundred Day Average Change -0.67585003
Two Hundred Day Average Change Percent -0.4704347
Type Disp Equity
Volume 248,268
Website https://www.filanatx.com
Zip 78,731